Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 1786 AL 1800

Amylin Pharmacology in Alzheimer's Disease Pathogenesis and Treatment

Corrigan RR, Piontkivska H, Casadesus G.

Curr Neuropharmacol. 2022;20(10):1894-1907. doi: 10.2174/1570159X19666211201093147.

BACE1: A Key Regulator in Alzheimer's Disease Progression and Current Development of its Inhibitors

Patel S, Bansoad AV, Singh R, Khatik GL.

Curr Neuropharmacol. 2022;20(6):1174-1193. doi: 10.2174/1570159X19666211201094031.

Synthesis and inhibitory activities of inhibitors for the treatment of Alzheimer's disease

Zhou S, Huang G.

Chem Biol Drug Des. 2022 May;99(5):727-735. doi: 10.1111/cbdd.14016. Epub 2022 Feb 10.

Warming needle moxibustion for Alzheimer's disease: A systematic review of randomized controlled trials

Chen X, Liu F, Lin N, Lin Q, Lyu Z, Xiu H, Nie P.

Geriatr Nurs. 2022 Jan-Feb;43:219-226. doi: 10.1016/j.gerinurse.2021.12.004.

Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Burden in Patients with Alzheimer's Disease: A Case Series

Dhaynaut M, Sprugnoli G, Cappon D, Macone J, Sanchez JS, Normandin MD, Guehl NJ, Koch G, Paciorek R, Connor A, Press D, Johnson K, Pascual-Leone A, El Fakhri G, Santarnecchi E.

J Alzheimers Dis. 2022;85(4):1667-1676. doi: 10.3233/JAD-215072.

Therapeutic Potential of Ferulic Acid in Alzheimer's Disease

Turkez H, Arslan ME, Barboza JN, Kahraman CY, de Sousa DP, Mardinoğlu A.

Curr Drug Deliv. 2022;19(8):860-873. doi: 10.2174/1567201819666211228153801.

Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease

Baakman AC, Gavan C, van Doeselaar L, de Kam M, Broekhuizen K, Bajenaru O, Camps L, Swart EL, Kalisvaart K, Schoonenboom N, Lemstra E, Scheltens P, Cohen A, van Gerven J, Groeneveld GJ.

Br J Clin Pharmacol. 2022 Jun;88(6):2814-2829. doi: 10.1111/bcp.15206. Epub 2022 Jan 26.

Imidazole: Multi-targeted Therapeutic Leads for the Management of Alzheimer's Disease

Dhingra AK, Chopra B, Jain A, Chaudhary J.

Mini Rev Med Chem. 2022;22(10):1352-1373. doi: 10.2174/1389557522666220104152141.

Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease

Pons V, Rivest S.

Pharmacol Rev. 2022 Jan;74(1):1-17. doi: 10.1124/pharmrev.121.000400.

Mechanistic and therapeutic implications of EphA-4 receptor tyrosine kinase in the pathogenesis of Alzheimer's disease

Ganguly D, Thomas JA, Ali A, Kumar R.

Eur J Neurosci. 2022 Nov;56(9):5532-5546. doi: 10.1111/ejn.15591. Epub 2022 Jan 13.

Potential innovation against Alzheimer's disorder: a tricomponent combination of natural antioxidants (vitamin E, quercetin, and basil oil) and the development of its intranasal delivery

Karthika C, Appu AP, Akter R, Rahman MH, Tagde P, Ashraf GM, Abdel-Daim MM, Hassan SSU, Abid A, Bungau S.

Environ Sci Pollut Res Int. 2022 Feb;29(8):10950-10965. doi: 10.1007/s11356-021-17830-7. Epub 2022 Jan 9.

Potential of triazines in Alzheimer's disease: A versatile privileged scaffold

Gharat R, Prabhu A, Khambete MP.

Arch Pharm (Weinheim). 2022 Apr;355(4):e2100388. doi: 10.1002/ardp.202100388. Epub 2022 Jan 11.

PDE1 inhibitors: a review of the recent patent literature (2008-present)

Le ML, Jiang MY, Han C, Yang YY, Wu Y.

Expert Opin Ther Pat. 2022 Apr;32(4):423-439. doi: 10.1080/13543776.2022.2027910. Epub 2022 Jan 31.

Fighting fire with fire: The immune system might be key in our fight against Alzheimer's disease

Dujardin P, Vandenbroucke RE, Van Hoecke L.

Drug Discov Today. 2022 May;27(5):1261-1283. doi: 10.1016/j.drudis.2022.01.004. Epub 2022 Jan 12.

Alzheimer disease and neuroplasticity

Koch G, Spampinato D.

Handb Clin Neurol. 2022;184:473-479. doi: 10.1016/B978-0-12-819410-2.00027-8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias